GLIPR1 and Miyoshi myopathy: Given that the down-regulation of tumour suppressor genes by hypermethylation of promoter CpG sites is a common feature of MM PCs [56, 62], it is possible that this mechanism underlies reduced GLIPR1 expression in at least some patients.